Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing paricalcitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alcohol + paricalcitol + propylene glycol 20%vv/5mcg/30%vv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alcohol and paricalcitol and propylene glycol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paricalcitol 5mcg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paricalcitol 5mcg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paricalcitol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing paricalcitol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 10 microgram/2 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 10 microgram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paricalcitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paricalcitol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paricalcitol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paricalcitol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |